Infectious disease (ID) and cardiometabolic disease (CMD) are two major global health challenges that affect millions of people every year. While these are distinct types of disease, there is growing evidence that they interact in complex ways, and that these interactions influence the risk, severity, and prognosis of both types of disease.
The Challenge is to understand the interactions between CMDs and IDs and inform how to best reduce the morbidity and mortality of people and populations exposed to both CMDs and IDs.